OECD Home › Health › Biotechnology policies › Latest Documents
The working papers included in this series cover a broad range of issues, of both a technical and policy-analytical nature, in the areas of science and technology.
The OECD and the ESRC Genomics Policy & Research Forum jointly organised a one-day Forum on 12 November 2012 in Paris. The event was both retrospective and forward-looking. The forum concluded that the promise of biotechnology is not set but evolves with fresh scientific knowledge, novel laws and regulations. The future of biotechnology needs to also integrate social and cultural dimensions.
This book introduces the concept of knowledge networks and markets (KNMs) in the life sciences, the emerging organisations and mechanisms to share and trade an increasing variety of knowledge assets.
This event was the first time the OECD has taken a systematic look at what marine biotechnology could contribute to the grand challenges of food and fuel security, population health, green growth and sustainable industries.
English, , 429kb
This guide comprises eight key points for planning public engagement activities. It contains a set of questions to help policy makers develop a plan from start to finish, as well as practical case studies from countries that have used the guide in their communication activities.
The Forum will explore topics such as regulatory considerations, skills and research support, intellectual property and community engagement. In addition, discussions will also focus on links between a ‘bioeconomy’ and synthetic biology.
This forum explored topics such as regulatory considerations, skills and research support, intellectual property and community engagement. In addition, discussions will also focus on links between a ‘bioeconomy’ and synthetic biology.
Carbon dioxide (CO2) has the second-largest direct contribution to the greenhouse effect of all gases. Since the beginning of the Industrial Revolution, the burning of fossil fuels has contributed to the increase in carbon dioxide in the atmosphere.
This report describes the scientific, industrial, regulatory, and health care management system context in which biomarkers are being developed. It identifies some of the barriers which may impede biomarker research, discovery, development, commercialisation and, ultimately, uptake in clinics.
This book examines international drivers, enabling technologies fast-tracking industrial biotechnology, industry trends, some products appearing on the market, industry structure and finance, and policy measures and trends. It examines separately biofuels, biobased chemicals and bioplastics.